AstraZeneca

In News

KOL Views Q&A: AstraZeneca's IL-33 could expand the reach of biologics in COPD - FirstWord Pharma

FirstWord Pharma - Apr 16, 2026

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance Australia

Yahoo Finance Australia - Apr 15, 2026

Imfinzi plus Imjudo combined with lenvatinib and TACE demonstrated a statistically significant and clinically meaningful improvement in progression-free survival in embolisation-eligible unresectable liver cancer in EMERALD-3 Phase III trial - AstraZeneca

AstraZeneca - Apr 02, 2026

Spanberger signs off on $191 million in grant funding for AstraZeneca plant - WVIR

WVIR - Apr 14, 2026

AstraZeneca stock holds steady after $191 million grant for Albemarle facility approved - Traders Union

Traders Union - Apr 15, 2026

Governor signs incentive bill for AstraZeneca facility in area - cbs19news.com

cbs19news.com - Apr 14, 2026

Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD - AstraZeneca

AstraZeneca - Mar 27, 2026

AstraZeneca plans to invest $15 billion in China through 2030 to pioneer the next-generation of innovative medicines - AstraZeneca

AstraZeneca - Jan 29, 2026

AstraZeneca announces historic agreement with US Government to lower the cost of medicines for American patients - AstraZeneca

AstraZeneca - Oct 10, 2025

AstraZeneca plans $2 billion manufacturing investment in Maryland, supporting 2,600 jobs and catalysing economic growth - AstraZeneca

AstraZeneca - Nov 21, 2025

Alexion data at 2026 AAN Annual Meeting reflects industry-leading portfolio and commitment to enhancing care across rare diseases - AstraZeneca

AstraZeneca - Apr 10, 2026

AstraZeneca reports positive EMERALD-3 results for HCC - Clinical Trials Arena

Clinical Trials Arena - Apr 06, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment